1. Mirabegron Ameliorated Atherosclerosis of ApoE -/- Mice in Chronic Intermittent Hypoxia but Not in Normoxia.
- Author
-
Wang Y, Wang Y, Jiang HF, Dang HM, Liu MR, Liu XY, Yu Y, Xie J, Zhan XJ, Zhang HN, and Wu XF
- Subjects
- Acetanilides, Animals, Apolipoproteins E, Disease Models, Animal, Humans, Hypoxia, Mice, Oxygen, Reactive Oxygen Species metabolism, Receptors, Adrenergic, Thiazoles, Atherosclerosis drug therapy, Atherosclerosis metabolism, Atherosclerosis prevention & control, Sleep Apnea, Obstructive complications, Sleep Apnea, Obstructive drug therapy
- Abstract
Purpose: It has been established that obstructive sleep apnea (OSA) is an independent risk factor for atherosclerosis. Chronic intermittent hypoxia (CIH) activates sympathoadrenal system and upregulates β3 adrenergic receptor (β3 AR). However, the effect of selective β3 AR agonist mirabegron in CIH-induced atherosclerosis remains unknown., Methods: We generated a CIH-induced atherosclerosis model through exposing ApoE
-/- mice to CIH (8 h per day, cyclic inspiratory oxygen fraction 5-21%, 60-s cycle) for 6 weeks after 4-week high-fat dieting and investigated the effects of mirabegron, a selective β3 AR agonist, on CIH-induced atherosclerosis. The coronary endarterectomy (CE) specimens from coronary artery disease patients with OSA and without OSA were collected., Results: The expression of β3 AR was significantly elevated in CIH-induced atherosclerosis model. Furthermore, treatment with mirabegron (10mg/kg per day by oral administration for 6 weeks) ameliorated atherosclerosis in ApoE-/- mice in CIH but not in normoxia. Mechanistically, mirabegron activated β3 AR and ameliorated intraplaque oxidative stress by suppressing p22phox expression and reactive oxygen species (ROS) level. In addition, in human CE specimens, β3 AR was also upregulated associated with increased p22phox expression and ROS level both in the lumen and in the plaque of coronary artery in OSA subjects., Conclusion: This study first demonstrated that mirabegron impeded the progression of CIH-induced atherosclerosis, at least in part, via β3 AR-mediated oxidative stress, suggesting a promising therapeutic strategy for protecting against atherosclerosis induced by CIH., (© 2021. Springer Science+Business Media, LLC, part of Springer Nature.)- Published
- 2022
- Full Text
- View/download PDF